Bookmark

Add to MyYahoo RSS

Chronic Bronchitis News

News on Chronic Bronchitis continually updated from thousands of sources around the net.

Tuesday | Freshnews

Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose...

Boehringer Ingelheim today announced that the U.S. Food and Drug Administration accepted for review the New Drug Application for the fixed-dose combination of tiotropium and olodaterol delivered via the Respimat inhaler for the proposed indication of long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic ... (more)

Comment?

Related Topix: Healthcare Law, Law, Food and Drug Administration, Medicine

Tuesday | Medical News Today

Increased lung cancer risk associated with previous pulmonary disease

Links between a number of common respiratory diseases and an increased risk of developing lung cancer have been found in a large pooled analysis of seven studies involving more than 25,000 individuals.

Comment?

Related Topix: Health, Lung Cancer, France, World News, Medicine, Smoking

Thu Aug 14, 2014

EurekAlert!

Previous pulmonary disease linked to increased lung cancer risk in large study

Links between a number of common respiratory diseases and an increased risk of developing lung cancer have been found in a large pooled analysis of seven studies involving more than 25,000 individuals.

Comment?

Related Topix: Health, Lung Cancer, France, World News, Medicine, Smoking

Sys-Con Media

FDA Advisory Committee Recommends Approval of Tiotropium RespimatA ...

If approved by the FDA, the proposed proprietary name for tiotropium bromide inhalation spray will be SpirivaA RespimatA .

Comment?

Related Topix: Healthcare Law, Law, Food and Drug Administration, Medicine, Chronic Obstructive Pulmonary Disease

Tue Aug 05, 2014

Fire Rescue Magazine

Using Popcorn to Illustrate Lung Disease for Students

Explaining the differences in pathophysiology between various lung diseases to new medic students can be a daunting task.

Comment?

Related Topix: Circulation, Health, Heart Failure

Fri Aug 01, 2014

Freshnews

FDA Approves Boehringer Ingelheim's StriverdiA RespimatA ...

Boehringer Ingelheim today announced that the U.S. Food and Drug Administration has approved Striverdi Respimat Inhalation Spray 5 mcg as a long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease , including chronic bronchitis and/or emphysema.

Comment?

Related Topix: Healthcare Law, Law, Food and Drug Administration, Medicine, Chronic Obstructive Pulmonary Disease, Health, Emphysema, Bronchitis

•••
•••
•••
•••
•••
•••
•••
•••